Managing localised cancer of the prostate

gan Ritchie, A W S
Cyhoeddwyd 1988

The distribution and possible significance of cells identified in human lymphoid tissue by the monoclonal antibody HNK-1.

gan Ritchie, A W, James, K, Micklem, H S
Cyhoeddwyd 1983

NATALI--a model for National Computer Databases in the investigation of new therapeutic techniques.

gan Braithwaite, B D, Ritchie, A W, Earnshaw, J J
Cyhoeddwyd 1995

Measures of mortality in prostatic cancer.

gan Goodman, C. M., Ritchie, A. W., Chisholm, G. D.
Cyhoeddwyd 1990

The influence of histological diagnosis on the postoperative complication rate following trans-urethral resection of prostate (TURP).

gan Crow, P., Gilbert, H. W., Jones, D. J., Ritchie, A. W. S.
Cyhoeddwyd 2002

Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies.

gan Ritchie, A W, Oswald, I, Micklem, H S, Boyd, J E, Elton, R A, Jazwinska, E, James, K
Cyhoeddwyd 1983

Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol

gan Sydes, M R, Spears, M R, Mason, M D, Clarke, N W, Dearnaley, D P, de Bono, J S, Attard, G, Chowdhury, S, Cross, W, Gillessen, S, Malik, Z I, Jones, R, Parker, C C, Ritchie, A W S, Russell, J M, Millman, R, Matheson, D, Amos, C, Gilson, C, Birtle, A, Brock, S, Capaldi, L, Chakraborti, P, Choudhury, A, Evans, L, Ford, D, Gale, J, Gibbs, S, Gilbert, D C, Hughes, R, McLaren, D, Lester, J F, Nikapota, A, O’Sullivan, J, Parikh, O, Peedell, C, Protheroe, A, Rudman, S M, Shaffer, R, Sheehan, D, Simms, M, Srihari, N, Strebel, R, Sundar, S, Tolan, S, Tsang, D, Varughese, M, Wagstaff, J, Parmar, M K B, James, N D
Cyhoeddwyd yn Ann Oncol (2018)

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

gan James, N.D., de Bono, J.S., Spears, M.R., Clarke, N.W., Mason, M.D., Dearnaley, D.P., Ritchie, A.W.S., Amos, C.L., Gilson, C., Jones, R.J., Matheson, D., Millman, R., Attard, G., Chowdhury, S., Cross, W.R., Gillessen, S., Parker, C.C., Russell, J.M., Berthold, D.R., Brawley, C., Adab, F., Aung, S., Birtle, A.J., Bowen, J., Brock, S., Chakraborti, P., Ferguson, C., Gale, J., Gray, E., Hingorani, M., Hoskin, P.J., Lester, J.F., Malik, Z.I., McKinna, F., McPhail, N., Money-Kyrle, J., O’Sullivan, J., Parikh, O., Protheroe, A., Robinson, A., Srihari, N.N., Thomas, C., Wagstaff, J., Wylie, J., Zarkar, A., Parmar, M.K.B., Sydes, M.R.
Cyhoeddwyd yn N Engl J Med (2017)

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial

gan Clarke, N W, Ali, A, Ingleby, F C, Hoyle, A, Amos, C L, Attard, G, Brawley, C D, Calvert, J, Chowdhury, S, Cook, A, Cross, W, Dearnaley, D P, Douis, H, Gilbert, D, Gillessen, S, Jones, R J, Langley, R E, MacNair, A, Malik, Z, Mason, M D, Matheson, D, Millman, R, Parker, C C, Ritchie, A W S, Rush, H, Russell, J M, Brown, J, Beesley, S, Birtle, A, Capaldi, L, Gale, J, Gibbs, S, Lydon, A, Nikapota, A, Omlin, A, O'Sullivan, J M, Parikh, O, Protheroe, A, Rudman, S, Srihari, N N, Simms, M, Tanguay, J S, Tolan, S, Wagstaff, J, Wallace, J, Wylie, J, Zarkar, A, Sydes, M R, Parmar, M K B, James, N D
Cyhoeddwyd yn Ann Oncol (2019)